GSK's swine flu vaccine launched

Pandemrix is one of two vaccines now available for swine flu prophylaxis in high-risk patients.

Pandemrix should be used in accordance with official guidance.

The dose recommendations are based on safety and immunogenicity data available from the administration of AS03-adjuvanted vaccine containing 3.75 microgram HA derived from A/Vietnam/1194/2004 (H5N1) in adults including the elderly. Half the dose was given to children 3-9 years old and doses were given on days 0 and 21.

Limited immunogenicity data suggest that a second dose may not be required in healthy adults aged 18-60 years.

View Pandemrix drug record

Further information: GSK


To sign up for the MIMS monthly news update, register at www.mims.co.uk/bulletins.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases